The anthelminthic agent albendazole does not interact with P-glycoprotein

Drug Metabolism and Disposition

Volumn 30, Issue 4, 2002, Pages 365-369

  Merino, Gracia ^a   Alvarez, Ana I ^a   Prieto, Julio G ^a   Kim, Richard B ^b  

^a UNIVERSITY OF LEÓN   (Spain)

^b VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBENDAZOLE; ANTHELMINTIC AGENT; GLYCOPROTEIN P; QUINIDINE; VERAPAMIL;

ANIMAL CELL; ARTICLE; DRUG ABSORPTION; DRUG DISPOSITION; DRUG DISTRIBUTION; DRUG METABOLISM; DRUG SOLUBILITY; DRUG TRANSPORT; NONHUMAN; PRIORITY JOURNAL; WORM INFECTION;

ALBENDAZOLE; ANIMALS; ANTHELMINTICS; ATP-BINDING CASSETTE TRANSPORTERS; BIOLOGICAL TRANSPORT; CACO-2 CELLS; CALCIUM CHANNEL BLOCKERS; CELL LINE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DIGOXIN; ENZYME INHIBITORS; HUMANS; LLC-PK1 CELLS; MALE; MICE; MICE, KNOCKOUT; P-GLYCOPROTEINS; QUINIDINE; SWINE; TISSUE DISTRIBUTION; VERAPAMIL;

ANIMALIA;

EID: 0036206218     PISSN: 00909556     EISSN: None     Source Type: Journal    
DOI: 10.1124/dmd.30.4.365     Document Type: Article

References (22)

1. Reducing intestinal nematode infection: Efficacy of albendazole and mebendazole
2. Pharmacological inhibition of P-glycoprotein transport enhances the distribution of HIV-1 protease inhibitors into brain and testes
3. Multidrug-resistance gene (P-glycoprotein) is expressed by endothelial cells at blood-brain barrier sites
4. Drug treatment of microsporidiosis
5. Elimination of lymphatic filariasis as a public health problem
6. In vitro sulfoxidation of albendazole by ovine liver microsomes: Assay and frequency of various xenobiotics
7. Function and expression of multidrug resistance-associate protein family in human colon adenocarcinoma cells (Caco-2)
8. The drug transporter P-glycoprotein limits oral absorption and brain entry of HIV-1 protease inhibitors
9. Interrelationship between substrates and inhibitors of human CYP3A and P-glycoprotein
10. Metabolic and toxicological aspects
11. Carbamazepine is not a substrate for P-glycoprotein
12. Characterization and inhibition by a wide range of xenobiotics of organic anion excretion by primary human hepatocytes
13. Factors affecting the absolute bioavailability of nifedipine
14. Relative contribution of cytochromes P450 and flavin-containing monooxygenases to the metabolism of albendazole by human liver microsomes
15. Presystemic metabolism of albendazole: Experimental evidence of an efflux process of albendazole sulfoxide to intestinal lumen
16. Influence of surfactants on oral bioavailability of albendazole based on the formation of the sulfoxide metabolites in rats
17. Study of the in vitro bioactivation of albendazole in human liver microsomes and hepatoma cell lines
18. Absence of the mdrla P-glycoprotein in mice affects tissue distribution and pharmacokinetics of dexamethasone, digoxin, and cyclosporin A
19. Albendazole sulfonation by rat liver cytochrome P-450c
20. Oral first-pass elimination of midazolam involves both gastrointestinal and hepatic CYP3A-mediated metabolism
21. P-glycoprotein as the drug efflux pump in primary cultured bovine brain capillary endothelial cells
22. Overlapping substrate specificities and tissue distribution of cytochrome P450 3A and P-glycoprotein: Implications for drug delivery and activity in cancer chemotherapy